Respiratory effects of opioid full and partial agonists in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 462-472

  Liguori, Anthony ^a   Morse, W H ^a   Bergman, Jack ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; BUTORPHANOL; CARBON DIOXIDE; LEVORPHANOL; METHADONE; NALBUPHINE; NALTREXONE; OPIATE AGONIST; QUADAZOCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CARBON DIOXIDE MEASUREMENT; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG WITHDRAWAL; NONHUMAN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; RHESUS MONKEY;

ANIMALS; BUPRENORPHINE; CARBON DIOXIDE; CODEINE; CONDITIONING (PSYCHOLOGY); LEVORPHANOL; MACACA MULATTA; NARCOTICS; RECEPTORS, OPIOID, MU; RESPIRATION;

EID: 0030430052     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ABBOUD, T. K., MOORE, M., ZHU, J., MURAKAWA, K., MINEHART, M , LONGHITANO, M., TERRASI, J., KLEPPER, I. D., CHOI, Y , KIMBALL, S. AND CHU, G.: Epidural butorphanol or morphine for the relief of post-cesarean section pain: ventilatory responses to carbon dioxide. Anesth. Analg. 66: 887-893, 1987.
2. BELLVILLE, J. W., ESCARRAGA, L. A., WALLENSTEIN, M. S. AND HOUDE, R. W.: The respiratory effects of codeine and morphine in man. Clin. Pharmacol. Ther. 9: 435-441, 1968.
3. BERTALMIO, A. J., MEDZIHRADSKY, F., WINGER, G. AND WOODS, J. H.: Differential influence of N-dealkylation on the stimulus properties of some opioid agonists. J. Pharmacol. Exp. Ther. 261: 278-284, 1992.
4. 2 analysis. J. Pharmacol. Exp. Ther. 243: 591-597, 1987.
5. BORISON, H. L.: Central nervous respiratory depressants: Narcotic analgesics. In Respiratory Pharmacology, ed. by J. G Widdicombe, pp. 53-63, Pergamon Press, New York, 1981
6. 2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys. J. Pharmacol. Exp. Ther. 264: 145-151, 1993.
7. BUTELMAN, E. R., WINGER, G., ZERNIG, G. AND WOODS, J. H.: Butorphanol: Characterization of agonist and antagonist effects in rhesus monkeys. J. Pharmacol. Exp. Ther. 272: 845-853, 1995.
8. DYKSTRA, L. A.: Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J. Pharmacol. Exp. Ther. 254: 245-252, 1990.
9. FRANCE, C. P., MEDZIHRADSKY, F. AND WOODS, J. H.: Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities. J. Pharmacol. Exp. Ther. 268: 47-58, 1994.
10. FRANCE, C. P. AND WOODS, J H.: Respiratory effects of receptor-selective opioids in rhesus monkeys. In The International Narcotics Research Conference (INRC) '89, ed. by R. Quirion, K. Jhamandas and C. Gianoulakis, pp. 295-298, A. R. Liss, New York, 1990.
11. GERAK, L. R., BUTELMAN, E. R., WOODS, J. H. AND FRANCE, C. P.: Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther 271: 993-999, 1994.
12. HORAN, P. J. AND HO, I. K.: Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol. Biochem. Behav. 34: 847-854, 1989.
13. HOUDE, R. W., WALLENSTEIN, S. L. AND BEAVER, W. T.: Clinical measurement of pain. In Analgetics, ed. by G. DeStevens, pp. 75-122, Academic Press Inc., New York, 1965.
14. HOWELL, L. L., BERGMAN, J. AND MORSE, W. H.: Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys. J. Pharmacol. Exp. Ther. 245: 364-372, 1988.
15. JAFFE, J. H. AND MARTIN, W. R.: Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics, 8th ed., ed by A. G. Gilman, L. S. Goodman and A. Gilman, pp. 485-521, Macmillan Publishing Co., New York, 1990.
16. JENNETT, S.: Assessment of respiratory effects of analgesic drugs. Br. J. Anaesth. 40: 746-756, 1968.
17. KENAKIN, T. P.: Pharmacologic Analysis of Drug-Receptor Interaction, 2nd ed., Raven Press, New York, 1993.
18. LASAGNA, L. AND BEECHER, H. K.: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. Exp. Ther. 122: 356-363, 1954.
19. LEANDER, J. D.: Evidence that nalorphine, butorphanol, and oxilorphan are partial agonists at the κ-opioid receptor. Eur. J. Pharmacol. 86: 467-470, 1983.
20. MARTIN, W. R.: Pharmacology of opioids. Pharmacol. Rev. 85: 283-323, 1983.
21. MCGILLIARD, K. L. AND TAKEMORI, A. E.: Antagonism by naloxone of narcotic-induced respiratory depression and analgesia. J. Pharmacol. Exp. Ther. 207: 494-503, 1978.
22. PACHTER, I. J. AND EVENS, R. P.: Butorphanol. Drug Alcohol Depend. 14: 325-338, 1985.
23. PRESTON, K. L., BIGELOW, G. E., BICKEL, W. K. AND LIEBSON, I. A.: Drug discrimination in human postaddicts: Agonist-antagonist opioids. J. Pharmacol. Exp. Ther. 250: 184-196, 1989.
24. ROMAGNOLI, A. AND KEATS, A. S.: Ceiling effect for respiratory depression by nalbuphine. Clin. Pharmacol. Ther. 27: 478-485, 1980.
25. ROSOW, C. E.: Butorphanol in perspective. Acute Care 12: suppl. 1, 2-7, 1988.
26. SHOOK, J. E., WATKINS, W. D. AND CAMPORESI, E. M.: Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am. Rev. Respir. Dis. 142: 895-909, 1990.
27. TALBERT, R. L., PETERS, J. I., SORRELLS, S. C. AND SIMMONS, R. S.: Respiratory effects of high-dose butorphanol. Acute Care 12: suppl. 1, 47-56, 1988.
28. WALKER, E. A., BUTELMAN, E. R., DECOSTA, B. R. AND WOODS, J. H.: Opioid thermal antinociception in rhesus monkeys: Receptor mechanisms and temperature dependency. J. Pharmacol. Exp. Ther. 267: 280-286, 1993.
29. WALKER, E. A., ZERNIG, G. AND WOODS, J. H.: Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure. J. Pharmacol. Exp. Ther. 273: 1345-1352, 1995.
30. WALSH, S. L., PRESTON, K. L., STITZER, M. L., CONE, E. J. AND BIGELOW, G. E.: Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin. Pharmacol. Ther. 55: 569-580, 1994.
31. WETTSTEIN, J. G., TEEPLE, E. S. AND MORSE, W. H.: Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys. J. Pharmacol. Exp. Ther. 255: 1328-1334, 1990.
32. WINGER, G., SKJOLDAGER, P. AND WOODS, J. H.: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J. Pharmacol. Exp. Ther. 261: 311-317, 1992.
33. WOODS, J. H., FRANCE, C. P. AND WINGER, G. D.: Behavioral pharmacology of buprenorphine: Issues relevant to its potential in treating drug abuse. NIDA Res. Monogr. 121: 12-27, 1992.
34. YOUNG, A. M., MASAKI, M. A. AND GUELA, C.: Discriminative stimulus effects of morphine: Effects of training dose on agonist and antagonist effects of mu opioids. J. Pharmacol. Exp. Ther. 261: 246-257, 1992.
35. YOUNG, A. M., STEPHENS, K. R., HEIN, D. W. AND WOODS, J. H.: Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J. Pharmacol. Exp. Ther. 229: 118-126, 1984.
36. ZUCKER, J. R., NEUENFELDT, T. AND FREUND, P. R.: Respiratory effects of nalbuphine and butorphanol in anesthetized patients. Anesth. Analg. 66, 1987.